OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Evodiamine Exhibits Anti-Bladder Cancer Activity by Suppression of Glutathione Peroxidase 4 and Induction of Ferroptosis
Che‐Yuan Hu, Hung‐Tsung Wu, Yan‐Shen Shan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6021-6021
Open Access | Times Cited: 8
Che‐Yuan Hu, Hung‐Tsung Wu, Yan‐Shen Shan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6021-6021
Open Access | Times Cited: 8
Showing 8 citing articles:
The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 62
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 62
Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics
Kuan Liu, Huijing Chen, Yanhong Li, et al.
Cancer Letters (2024) Vol. 591, pp. 216867-216867
Closed Access | Times Cited: 5
Kuan Liu, Huijing Chen, Yanhong Li, et al.
Cancer Letters (2024) Vol. 591, pp. 216867-216867
Closed Access | Times Cited: 5
The Interplay between Medical Plants and Gut Microbiota in Cancer
Santino Caserta, Claudia Genovese, Nicola Cicero, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3327-3327
Open Access | Times Cited: 11
Santino Caserta, Claudia Genovese, Nicola Cicero, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3327-3327
Open Access | Times Cited: 11
Mechanisms of ferroptosis and targeted therapeutic approaches in urological malignancies
Wenjie Ma, Xiaotian Jiang, Ruipeng Jia, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Wenjie Ma, Xiaotian Jiang, Ruipeng Jia, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs
George J. Kontoghiorghes
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16749-16749
Open Access | Times Cited: 6
George J. Kontoghiorghes
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16749-16749
Open Access | Times Cited: 6
Ferroptosis: An Emerging Target for Bladder Cancer Therapy
Zhengda Shan, Wenbin Tang, Zhiyuan Shi, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 8201-8214
Open Access | Times Cited: 5
Zhengda Shan, Wenbin Tang, Zhiyuan Shi, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 8201-8214
Open Access | Times Cited: 5
Current and Potential Roles of Ferroptosis in Bladder Cancer
Wenxin An, Radheshyam Gupta, Kun Zhai, et al.
Current Medical Science (2023) Vol. 44, Iss. 1, pp. 51-63
Closed Access | Times Cited: 3
Wenxin An, Radheshyam Gupta, Kun Zhai, et al.
Current Medical Science (2023) Vol. 44, Iss. 1, pp. 51-63
Closed Access | Times Cited: 3
Molecular mechanisms of ferroptosis and its effects on bladder cancer.
Ruijie Li, Yiping Ning, Yacheng Yuan, et al.
PubMed (2024) Vol. 49, Iss. 2, pp. 286-295
Closed Access
Ruijie Li, Yiping Ning, Yacheng Yuan, et al.
PubMed (2024) Vol. 49, Iss. 2, pp. 286-295
Closed Access
